Vaccitech Renames as Barinthus Biotherapeutics to Highlight

New Corporate Brand to be Unveiled at AASLD Liver Meeting® 2023 with Interim Data OXFORD, United Kingdom, Nov. 06, 2023 (GLOBE NEWSWIRE) -- Barinthus...

Related Keywords

Ankara , Turkey , Israel , Gaza , Israel General , Ukraine , Boston , Massachusetts , United States , United Kingdom , Britain , Christopherm Calabrese , Kevin Gardner , King Arthur , Barinthus Biotherapeutic , Barinthus Biotherapeutics , Jonothan Blackbourn , Astrazeneca Oxford , Audra Friis , Arbutus Biopharma Corporation , University Of Oxford , Exchange Commission , Nasdaq , Sam Brown Inc , New Corporate Brand , American Association , Liver Diseases , Liver Meeting , Bill Enright , Chief Executive Officer , Preliminary Pharmacodynamics , Repeat Dosing , Virally Suppressed , Non Cirrhotic Subjects , Arbutus Biopharma , Abstract Acceptance , Open Label Study , Treatment Regimens , Low Dose Nivolumab , New Therapies , Modified Vaccinia Ankara , Hepatitisb Virus , East Asia , Private Securities Litigation Reform Act , Annual Report , Quarterly Reports , Nasdaq Vacc , Accitech Uk Limited ,